| Artículo |
Autor |
Tema |
| Self-care behaviours: state of the art |
Jaarsma, Tiny (Groningen, NL) |
Insuficiencia cardiaca |
| Assessing mitral insufficiency and its consequences in the individual patient |
THOMAS James D. (Cleveland, US) |
Valvulopatía |
| Inodilators and myosin activators. |
Nieminen, Markku S. (Helsinki, FI) |
|
| Human embryonic stem cell-derived cardiomyocytes: Are they the real thing? |
Harding, Sian E. (London, GB) |
Ciencias básicas |
| Mechanisms of diastolic dysfunction. How important are endothelial factors? |
Paulus, Walter (Amsterdam, NL) |
Insuficiencia cardiaca |
| Non adherence to medication: scope of the problem and predictors |
Van der Wal, Martje (Groningen, NL) |
Insuficiencia cardiaca |
| Extending the indications for aldosterone antagonists |
Zannad, Faiez (Dommartin les Toul, FR) |
Insuficiencia cardiaca |
| Monitoring patient symptoms remotely: What skills are needed? |
Ekman, Inger (Goteborg, SE) |
Insuficiencia cardiaca |
| State of the art: prognostication |
Jourdain, Patrick (Pontoise, FR) |
Insuficiencia cardiaca |
| Response and adaptation to hypoxia |
Schumacker, Paul (Chicago, US) |
Ciencias básicas |
| Unsolved issues |
Piepoli, Massimo F. (Piacenza, IT) |
|
| Treatment Strategies |
McKelvie, Robert (Hamilton, CA) |
Insuficiencia cardiaca |
| Targeting the cardiorenal syndrome: adenosine A1 antagonists |
Metra, Marco (Brescia, IT) |
Insuficiencia cardiaca |
| Health economics for the clinician - what do we need to know? |
Cowie, Martin R. (London, GB) |
Insuficiencia cardiaca |
| Future directions |
Braunschweig, Frieder (Stockholm, SE) |
Insuficiencia cardiaca |
| Mechanisms of transition from hypertension to heart failure: The heart |
Voors, Adriaan A. (Groningen, NL) |
|
| Implications of the obesity and diabetes epidemic for heart failure : The European view |
Voors, Adriaan A (Groningen, NL) |
Insuficiencia cardiaca |
| Use of CRT-P, CRT-D and ICD in Europe |
Gasparini, Maurizio (Rozzano, IT) |
Insuficiencia cardiaca |
| Biomarkers |
Mc Donagh TA (London, UK) |
|
| Non cardiovascular mortality in heart failure trials. |
Solomon S. (Boston, US) |
|
| What information does the clinician need from MRI? |
Bax JJ (Leiden, NL) |
|
| Assessment of symptoms in clinics and trials. |
Cleland J G F (Kingston upon Hull, GB) |
|
| Devices in heart failure: How to optimize follow up |
Stellbrink C (Bielefeld, DE) |
|
| Unconventional end-points in heart failure trials. |
Cleland J G F (Kingston upon Hull, GB) |
|